ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for Viz ICH; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-08FDA-cleared profile
Viz.ai, Inc. · CT/CTA · FDA-cleared (510(k))
Authorized purpose: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage, with specialist notification; results do not replace diagnostic interpretation.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Notification-only triage of adult noncontrast head CT for suspected intracranial hemorrhage, with specialist notification; results do not replace diagnostic interpretation.
Evidence takeaway. Evidence from the reviewed source record: A retrospective study evaluated Viz ICH on 261 non-contrast CT scans from two U.S. clinical sites. Sensitivity was 93% (87%-97%), specificity was 90% (84%-94%), and AUC was 0.96; average time to alerting a specialist was 0.49±0.15 minutes versus 38.2±84.3 minutes for standard-of-care notification.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
Packet wording: "Viz ICH is a notification-only, parallel workflow tool for use by hospital networks and trained clinicians to identify and communicate images of specific patients to a specialist, independent of standard of care workflow." … "the device analyzes non-contrast CT images of the brain acquired in the acute setting, and sends notifications to a neurovascular or neurosurgical specialist that a suspected intracranial hemorrhage has been identified and recommends review of those images.". Read from the exact FDA decision document on 2026-11-14.
The exact device description states the NCCT head-image and DICOM-router input path.
The exact packet supports specialist notification and non-diagnostic mobile image viewing.
Packet wording: "Viz ICH is a notification-only, parallel workflow tool for use by hospital networks and trained clinicians to identify and communicate images of specific patients to a specialist," … "Specifically, the device analyzes non-contrast CT images of the brain acquired in the acute setting,". Read from the exact FDA decision document on 2026-11-14.
These are the user and specialist descriptions stated in the exact indication and device description.
These are the exact preview, diagnostic-use, full-evaluation, and scanner-manufacturer boundaries in the packet.
The exact packet reports these study design, performance, and notification-time results; the dossier's unsupported metric list is replaced.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
The exact packet reports these study design, performance, and notification-time results; the dossier's unsupported metric list is replaced.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not verified: Pricing information is recorded but not verified against a resolving source.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: NCCT images of the head acquired on a local healthcare network and transmitted by a DICOM router to the backend server.
Scope: Exact FDA submission. The exact device description states the NCCT head-image and DICOM-router input path.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-19 · FDA K193658: Viz ICH
Source context, not route validation: The exact FDA package describes Viz ICH using a DICOM router that identifies relevant images on a local IT network and transfers them to a Backend Server using a DICOM compliant communication protocol, with notifications sent to a mobile application. Interface versions and local compatibility require confirmation.
Scope: Exact FDA submission. Packet wording: "Viz ICH consists of backend and mobile application component software. The Backend software includes a DICOM router and backend server." … "via a DICOM router that automatically identifies relevant images on a local IT Network and transfers them to a Backend Server using a DICOM compliant communication protocol.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-11-14 · FDA K193658: Viz ICH
Source context, not route validation: The exact FDA package describes Viz ICH as backend and mobile application software, in which a DICOM router sends images from the local hospital network to a remote Backend Server for processing and analysis, and a mobile application receives notifications. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "Viz ICH consists of backend and mobile application component software. The Backend software includes a DICOM router and backend server." … "Viz ICH and its primary predicate, ContaCT (DEN170073), use the same process of automatic data identification and transfer to send images from the local hospital network to a remote server for image processing and analysis,". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-11-14 · FDA K193658: Viz ICH
Source context, not route validation: A notification to a neurovascular or neurosurgical specialist that suspected intracranial hemorrhage has been identified, with analyzed NCCT images viewable through a non-diagnostic mobile application.
Scope: Exact FDA submission. The exact packet supports specialist notification and non-diagnostic mobile image viewing.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-19 · FDA K193658: Viz ICH
Unresolved route: A notification to a neurovascular or neurosurgical specialist that suspected intracranial hemorrhage has been identified, with analyzed NCCT images viewable through a non-diagnostic mobile application.
Scope: Exact FDA submission. The exact packet supports specialist notification and non-diagnostic mobile image viewing.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-19 · FDA K193658: Viz ICH
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Packet wording: "Viz ICH consists of backend and mobile application component software. The Backend software includes a DICOM router and backend server." … "Viz ICH and its primary predicate, ContaCT (DEN170073), use the same process of automatic data identification and transfer to send images from the local hospital network to a remote server for image processing and analysis,". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Packet wording: "Viz ICH consists of backend and mobile application component software. The Backend software includes a DICOM router and backend server." … "via a DICOM router that automatically identifies relevant images on a local IT Network and transfers them to a Backend Server using a DICOM compliant communication protocol.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Vendor-wide statement, not an independent attestation. It does not establish certificate or report scope for this exact release, expiry, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.
User qualification wording only; the summary specifies no training program or training offering for this device.
Vendor statements, not attestations. Certificates and audit reports were not read; the trust center names Viz.ai generally and does not scope these commitments to any specific product release; exact-release scope is not established.
ACR AI Central provides an exact-submission model card for Viz ICH; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-08Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
The exact packet identifies the subject imaging modality as non-contrast CT and does not establish the dossier's CT/CTA value. Controlled directory display reconciled from exact FDA wording: Non-contrast CT (NCCT). -> CT/CTA.
Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The refreshed discovery snapshot contains 2 PubMed and 2 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 2 PubMed and 2 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public price or quote for the exact K193658 configuration was established in this review.
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
10 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary, deployment, integration
Scope: regulatoryIdentity, modalityContext
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: postmarketSafety
Scope: security
Scope: security
Scope: security
Regulatory record
510(k)
Research record
fda record reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Methinks Software S.L.
Authorized purpose: Methinks CTA Stroke analyzes acute-setting brain CT angiography in adults over 21 with suspected stroke for suspected large-vessel occlusion in the terminal ICA, MCA-M1, or MCA-M2 and sends PACS and/or specialist notifications in parallel to standard care; previews are informational and not diagnostic.
iSchemaView
Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.
Methinks Software S.L.
Authorized purpose: Methinks NCCT Stroke analyzes adult non-contrast head CT to flag suspected intracranial hemorrhage and suspected large-vessel occlusion of the ICA, MCA-M1, or MCA-M2 for parallel workflow triage via PACS and/or notifications; previews are informational, not diagnostic, and a negative notification does not rule out LVO or replace CTA/standard care.
JLK, Inc.
Authorized purpose: Notification-only triage of suspected intracranial hemorrhage on non-contrast head CT
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history